These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31286996)

  • 1. Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options.
    Quintanilla ME; Ezquer F; Morales P; Santapau D; Berríos-Cárcamo P; Ezquer M; Herrera-Marschitz M; Israel Y
    Stem Cell Res Ther; 2019 Jul; 10(1):205. PubMed ID: 31286996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal delivery of mesenchymal stem cell-derived exosomes reduces oxidative stress and markedly inhibits ethanol consumption and post-deprivation relapse drinking.
    Ezquer F; Quintanilla ME; Morales P; Santapau D; Ezquer M; Kogan MJ; Salas-Huenuleo E; Herrera-Marschitz M; Israel Y
    Addict Biol; 2019 Sep; 24(5):994-1007. PubMed ID: 30239077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated mesenchymal stem cell administration inhibits chronic alcohol drinking and suppresses relapse-like drinking in high-alcohol drinker rats.
    Ezquer F; Quintanilla ME; Morales P; Ezquer M; Lespay-Rebolledo C; Herrera-Marschitz M; Israel Y
    Addict Biol; 2019 Jan; 24(1):17-27. PubMed ID: 29044813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and N-acetylcysteine co-administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation-oxidative stress self-perpetuation.
    Israel Y; Quintanilla ME; Ezquer F; Morales P; Santapau D; Berríos-Cárcamo P; Ezquer M; Olivares B; Herrera-Marschitz M
    Addict Biol; 2021 Jan; 26(1):e12853. PubMed ID: 31733014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence.
    Quintanilla ME; Quezada M; Morales P; Berríos-Cárcamo P; Santapau D; Ezquer M; Herrera-Marschitz M; Israel Y; Ezquer F
    Transl Psychiatry; 2022 Nov; 12(1):462. PubMed ID: 36333316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and cell therapy on the acquisition and relapse-like binge drinking in a model of alcoholism: translational options.
    Yedy Israel ; Quintanilla ME; Ezquer F; Morales P; Rivera-Meza M; Karahanian E; Ezquer M; Herrera-Marschitz M
    Gene Ther; 2019 Nov; 26(10-11):407-417. PubMed ID: 30820030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commonality of Ethanol and Nicotine Reinforcement and Relapse in Wistar-Derived UChB Rats: Inhibition by N-Acetylcysteine.
    Quintanilla ME; Morales P; Ezquer F; Ezquer M; Herrera-Marschitz M; Israel Y
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1988-1999. PubMed ID: 30035805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Administration of Mesenchymal Stem Cell Secretome Reduces Hippocampal Oxidative Stress, Neuroinflammation and Cell Death, Improving the Behavioral Outcome Following Perinatal Asphyxia.
    Farfán N; Carril J; Redel M; Zamorano M; Araya M; Monzón E; Alvarado R; Contreras N; Tapia-Bustos A; Quintanilla ME; Ezquer F; Valdés JL; Israel Y; Herrera-Marschitz M; Morales P
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence.
    Quezada M; Ponce C; Berríos-Cárcamo P; Santapau D; Gallardo J; De Gregorio C; Quintanilla ME; Morales P; Ezquer M; Herrera-Marschitz M; Israel Y; Andrés-Herrera P; Hipólito L; Ezquer F
    CNS Neurosci Ther; 2024 Apr; 30(4):e14517. PubMed ID: 37927136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous administration of anti-inflammatory mesenchymal stem cell spheroids reduces chronic alcohol intake and abolishes binge-drinking.
    Ezquer F; Morales P; Quintanilla ME; Santapau D; Lespay-Rebolledo C; Ezquer M; Herrera-Marschitz M; Israel Y
    Sci Rep; 2018 Mar; 8(1):4325. PubMed ID: 29567966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetylcysteine and Acetylsalicylic Acid Inhibit Alcohol Consumption by Different Mechanisms: Combined Protection.
    Quintanilla ME; Ezquer F; Morales P; Ezquer M; Olivares B; Santapau D; Herrera-Marschitz M; Israel Y
    Front Behav Neurosci; 2020; 14():122. PubMed ID: 32848653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of
    Quintanilla ME; Morales P; Ezquer F; Ezquer M; Herrera-Marschitz M; Israel Y
    Front Behav Neurosci; 2020; 14():617418. PubMed ID: 33633548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dual mechanism fully blocks ethanol relapse: Role of vagal innervation.
    Quintanilla ME; Ezquer F; Morales P; Santapau D; Ezquer M; Herrera-Marschitz M; Israel Y
    Addict Biol; 2022 Mar; 27(2):e13140. PubMed ID: 35229957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition, Maintenance and Relapse-Like Alcohol Drinking: Lessons from the UChB Rat Line.
    Israel Y; Karahanian E; Ezquer F; Morales P; Ezquer M; Rivera-Meza M; Herrera-Marschitz M; Quintanilla ME
    Front Behav Neurosci; 2017; 11():57. PubMed ID: 28420969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The administration of Alda-1, an activator of ALDH2, inhibits relapse-like ethanol intake in female alcohol-preferring UChB rats.
    Quilaqueo ME; Adasme S; Solís-Egaña F; Quintanilla ME; Vásquez D; Morales P; Herrera-Marschitz M; Rivera-Meza M
    Life Sci; 2023 Sep; 328():121876. PubMed ID: 37348813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression.
    Sari Y; Toalston JE; Rao PSS; Bell RL
    Neuroscience; 2016 Jun; 326():117-125. PubMed ID: 27060486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player.
    Ezquer F; Quintanilla ME; Morales P; Santapau D; Munita JM; Moya-Flores F; Ezquer M; Herrera-Marschitz M; Israel Y
    Drug Alcohol Depend; 2022 Jul; 236():109466. PubMed ID: 35489181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.
    Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M
    Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-exposure to nicotine-associated context from adolescence enhances alcohol intake in adulthood.
    Zipori D; Sadot-Sogrin Y; Goltseker K; Even-Chen O; Rahamim N; Shaham O; Barak S
    Sci Rep; 2017 May; 7(1):2479. PubMed ID: 28559549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased alcohol preference and intake in nicotine-preferring rats.
    Ozturk B; Pogun S; Kanit L
    Am J Drug Alcohol Abuse; 2020 Jul; 46(4):408-420. PubMed ID: 31860364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.